So, although inhibition of Glutaminolysis in tumor cells is effective, it has not completely cleared the tumor lesions, which may be related to the tendency of CD4+ T differentiation changes to Treg after Glutaminolysis inhibition. The gene discussed is CD4; the disease is neoplasm.